#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholangiocarcinoma Antiphospholipid antibodies Angiosarcoma recurrent Cataract Ehlers-Danlos syndrome Ornithine transcarbamoylase deficiency Glomerulonephritis membranoproliferative Small cell lung cancer Precursor T-lymphoblastic lymphoma/leukaemia recurrent Breast angiosarcoma metastatic Hypophosphatasia Kaposi's sarcoma Osteosarcoma Lymphoma Thrombotic microangiopathy More trials…

    Learn about Rare Diseases

    Pleural mesothelioma malignant – Trials in Disease Pulmonary sarcoidosis – Life with Disease Hereditary ataxia – Life with Disease Immunodeficiency congenital Familial amyotrophic lateral sclerosis – Basic Information Haemophilia – Treatment Synovial sarcoma metastatic – Basic Information Ewing’s sarcoma metastatic – Diagnostics Pemphigus – Life with Disease Haemophilia A with anti factor VIII – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GLYCYL-TYROSINE Ep0042 Sodium Iotalamate (125I) Panobinostat Nitric Oxide AZD6234 Calcium Chloride Dihydrate Emactuzumab Sxr1096 Deferoxamine Ioversol Nalbuphine Hydrochloride Sodium Lactate Inebilizumab Zanubrutinib Atomoxetine Hydrochloride Desoximetasone Navtemadlin Fluticasone Propionate ALXN1920 More therapies…

    Learn about Your Condition

    Clinically isolated syndrome Fatty acid oxidation disorder Gastrooesophageal cancer Supraventricular tachycardia Drug dependence Osteomyelitis Breast conserving surgery Sexual dysfunction Pigmentary glaucoma Rhabdomyosarcoma recurrent Myxofibrosarcoma Immune thrombocytopenia Adenosquamous cell lung cancer Metastases to lymph nodes Atrophic vulvovaginitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Polyclinic Victus

Polyclinic Victus

Kneza Mislava 15, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Atorvastatin
    • Inclisiran
    • Rosuvastatin
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!